Pnc Financial Services Group, Inc. Pacira Bio Sciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,597 shares of PCRX stock, worth $85,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,597
Previous 3,084
16.63%
Holding current value
$85,140
Previous $46,000
45.65%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$125 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$77.2 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.4 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$47.2 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.08B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...